Skip to content

HomeLatest News
CompaniesExplore European Tech
ResearchAll published research
ThemesExplore the industries
Events & EarningsDates to follow
Our MissionLearn & Share

Join free Log in

Research

Research & articles Research Notes Company updates

Search research or companiesClear filters

CompanyCountryTechnologyPublication yearOrder

Official announcements retain their original headline and source language.

12 results

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Company updateOct 28, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

Company updateSep 23, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

Company updateSep 9, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR to Participate in Upcoming Investor Conferences in September 2026

Company updateSep 2, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces Second Quarter 2026 Operating and Financial Results

Company updateAug 13, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

Company updateJun 25, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

Company updateJun 25, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces First Quarter 2026 Operating and Financial Results

Company updateMay 12, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

Company updateMay 11, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

Company updateMay 4, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors

Company updateApr 30, 2026ProQR Therapeutics N.V.Company announcement feed

ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event

Company updateApr 8, 2026ProQR Therapeutics N.V.Company announcement feed

© 2026 European Tech Equities

X LinkedInSources Privacy Terms

Search companies & research

Search companies & research